Why the study?
Hypertrophic cardiomyopathy is a heterogeneous myocardial disease often caused by sarcomeric gene mutations, with MYH7 being one of the most common.
Answers are grounded in this paper and cite their sources.
The successful generation of this MYH7-mutant iPSC line provides a valuable in vitro model for studying the molecular mechanisms of hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy (HCM) is a heterogeneous myocardial disease often caused by sarcomeric gene mutations. MYH7 is one of the most common genes associated with HCM. In this study, we generated a human induced pluripotent stem cell (iPSC) line ZZUNEUi020-A from peripheral blood mononuclear cells of a female HCM patient with the p. R719Q (c. 2156G > A) mutation in MYH7. This cell line expressed pluripotency markers, showed normal female karyotype and could differentiate into all three germ layers in vitro.
No takes yet. Share an insight, caveat, or question.
Li et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: